<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 19 Feb 2026 04:18:14 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR330 at UBS</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR330+at+UBS/26024977.html</link>
   <description>UBS analyst Xian Deng raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR330.00  (from EUR300.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR330+at+UBS/26024977.html</guid>
   <pubDate>Thu, 19 Feb 2026 04:18:14 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR330 at UBS</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR330+at+UBS/26024977.html</link>
   <description>UBS analyst Xian Deng raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR330.00  (from EUR300.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR330+at+UBS/26024977.html</guid>
   <pubDate>Thu, 19 Feb 2026 04:18:14 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR330 at UBS</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR330+at+UBS/26024977.html</link>
   <description>UBS analyst Xian Deng raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR330.00  (from EUR300.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR330+at+UBS/26024977.html</guid>
   <pubDate>Thu, 19 Feb 2026 04:18:14 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR330 at UBS</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR330+at+UBS/26024977.html</link>
   <description>UBS analyst Xian Deng raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR330.00  (from EUR300.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR330+at+UBS/26024977.html</guid>
   <pubDate>Thu, 19 Feb 2026 04:18:14 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR304 at Goldman Sachs</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR304+at+Goldman+Sachs/26003271.html</link>
   <description>Goldman Sachs analyst Rajan Sharma raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR304.00  (from EUR255.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR304+at+Goldman+Sachs/26003271.html</guid>
   <pubDate>Mon, 16 Feb 2026 02:32:25 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR304 at Goldman Sachs</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR304+at+Goldman+Sachs/26003271.html</link>
   <description>Goldman Sachs analyst Rajan Sharma raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR304.00  (from EUR255.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR304+at+Goldman+Sachs/26003271.html</guid>
   <pubDate>Mon, 16 Feb 2026 02:32:25 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR304 at Goldman Sachs</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR304+at+Goldman+Sachs/26003271.html</link>
   <description>Goldman Sachs analyst Rajan Sharma raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR304.00  (from EUR255.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR304+at+Goldman+Sachs/26003271.html</guid>
   <pubDate>Mon, 16 Feb 2026 02:32:25 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR304 at Goldman Sachs</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR304+at+Goldman+Sachs/26003271.html</link>
   <description>Goldman Sachs analyst Rajan Sharma raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR304.00  (from EUR255.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR304+at+Goldman+Sachs/26003271.html</guid>
   <pubDate>Mon, 16 Feb 2026 02:32:25 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>TD Cowen on UCB SA (UCB:BB) (UCBJY): 'Impressive Bimzelx 2025 Performance To Continue In 2026'</title>
   <link>http://www.streetinsider.com/Intl+Ratings/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27Impressive+Bimzelx+2025+Performance+To+Continue+In+2026%27/25905429.html</link>
   <description>&lt;p&gt;TD Cowen analyst Stacy Ku reiterated a Buy rating and EUR300.00 price target on UCB SA (UCB:BB) (OTC: UCBJY).&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;Impressive Bimzelx 2025 Performance To Continue In 2026; UCB's 2025 revenue guide &quot;above €7.6B&quot; confirms strong Bimzelx sales, although investor focus has shifted to a well-understood Briviact LOE/2026 guidance, Bimzelx's HS trajectory, and donzakimig update. Bimzelx is again set for outperformance in 2026, with the correct strategy to maximize Bimzelx value. At 2026 Bimzelx consensus, our €300 PT is ~20-21x '27E EPS, with significant upside potential. We expect UCB to exceed the Street's H2 expectations of €3,964MM (+18% Y/Y,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27Impressive+Bimzelx+2025+Performance+To+Continue+In+2026%27/25905429.html</guid>
   <pubDate>Wed, 28 Jan 2026 09:27:19 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>TD Cowen on UCB SA (UCB:BB) (UCBJY): 'Impressive Bimzelx 2025 Performance To Continue In 2026'</title>
   <link>http://www.streetinsider.com/Intl+Ratings/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27Impressive+Bimzelx+2025+Performance+To+Continue+In+2026%27/25905429.html</link>
   <description>&lt;p&gt;TD Cowen analyst Stacy Ku reiterated a Buy rating and EUR300.00 price target on UCB SA (UCB:BB) (OTC: UCBJY).&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;Impressive Bimzelx 2025 Performance To Continue In 2026; UCB's 2025 revenue guide &quot;above €7.6B&quot; confirms strong Bimzelx sales, although investor focus has shifted to a well-understood Briviact LOE/2026 guidance, Bimzelx's HS trajectory, and donzakimig update. Bimzelx is again set for outperformance in 2026, with the correct strategy to maximize Bimzelx value. At 2026 Bimzelx consensus, our €300 PT is ~20-21x '27E EPS, with significant upside potential. We expect UCB to exceed the Street's H2 expectations of €3,964MM (+18% Y/Y,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27Impressive+Bimzelx+2025+Performance+To+Continue+In+2026%27/25905429.html</guid>
   <pubDate>Wed, 28 Jan 2026 09:27:19 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>TD Cowen on UCB SA (UCB:BB) (UCBJY): 'Impressive Bimzelx 2025 Performance To Continue In 2026'</title>
   <link>http://www.streetinsider.com/Analyst+Comments/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27Impressive+Bimzelx+2025+Performance+To+Continue+In+2026%27/25905429.html</link>
   <description>&lt;p&gt;TD Cowen analyst Stacy Ku reiterated a Buy rating and EUR300.00 price target on UCB SA (UCB:BB) (OTC: UCBJY).&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;Impressive Bimzelx 2025 Performance To Continue In 2026; UCB's 2025 revenue guide &quot;above €7.6B&quot; confirms strong Bimzelx sales, although investor focus has shifted to a well-understood Briviact LOE/2026 guidance, Bimzelx's HS trajectory, and donzakimig update. Bimzelx is again set for outperformance in 2026, with the correct strategy to maximize Bimzelx value. At 2026 Bimzelx consensus, our €300 PT is ~20-21x '27E EPS, with significant upside potential. We expect UCB to exceed the Street's H2 expectations of €3,964MM (+18% Y/Y,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27Impressive+Bimzelx+2025+Performance+To+Continue+In+2026%27/25905429.html</guid>
   <pubDate>Wed, 28 Jan 2026 09:27:19 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>TD Cowen on UCB SA (UCB:BB) (UCBJY): 'Impressive Bimzelx 2025 Performance To Continue In 2026'</title>
   <link>http://www.streetinsider.com/Analyst+Comments/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27Impressive+Bimzelx+2025+Performance+To+Continue+In+2026%27/25905429.html</link>
   <description>&lt;p&gt;TD Cowen analyst Stacy Ku reiterated a Buy rating and EUR300.00 price target on UCB SA (UCB:BB) (OTC: UCBJY).&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;Impressive Bimzelx 2025 Performance To Continue In 2026; UCB's 2025 revenue guide &quot;above €7.6B&quot; confirms strong Bimzelx sales, although investor focus has shifted to a well-understood Briviact LOE/2026 guidance, Bimzelx's HS trajectory, and donzakimig update. Bimzelx is again set for outperformance in 2026, with the correct strategy to maximize Bimzelx value. At 2026 Bimzelx consensus, our €300 PT is ~20-21x '27E EPS, with significant upside potential. We expect UCB to exceed the Street's H2 expectations of €3,964MM (+18% Y/Y,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27Impressive+Bimzelx+2025+Performance+To+Continue+In+2026%27/25905429.html</guid>
   <pubDate>Wed, 28 Jan 2026 09:27:19 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR310 at Barclays</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR310+at+Barclays/25815889.html</link>
   <description>Barclays analyst Charles Pitman raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR310.00  (from EUR270.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR310+at+Barclays/25815889.html</guid>
   <pubDate>Wed, 07 Jan 2026 02:39:36 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR310 at Barclays</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR310+at+Barclays/25815889.html</link>
   <description>Barclays analyst Charles Pitman raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR310.00  (from EUR270.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR310+at+Barclays/25815889.html</guid>
   <pubDate>Wed, 07 Jan 2026 02:39:36 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR310 at Barclays</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR310+at+Barclays/25815889.html</link>
   <description>Barclays analyst Charles Pitman raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR310.00  (from EUR270.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR310+at+Barclays/25815889.html</guid>
   <pubDate>Wed, 07 Jan 2026 02:39:36 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR310 at Barclays</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR310+at+Barclays/25815889.html</link>
   <description>Barclays analyst Charles Pitman raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR310.00  (from EUR270.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR310+at+Barclays/25815889.html</guid>
   <pubDate>Wed, 07 Jan 2026 02:39:36 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>TD Cowen on UCB SA (UCB:BB) (UCBJY): 'KOL Survey Indicates Continued HS Market Growth'</title>
   <link>http://www.streetinsider.com/Intl+Ratings/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27KOL+Survey+Indicates+Continued+HS+Market+Growth%27/25738364.html</link>
   <description>&lt;p&gt;TD Cowen analyst Stacy Ku reiterated a Buy rating and EUR300.00 price target on UCB SA (UCB:BB) (OTC: UCBJY).&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;KOL Survey Indicates Continued HS Market Growth And Meaningful Bimzelx Adoption; Investor inbounds are still focused on the HS market dynamics for Bimzelx. All the KOL survey responses point to con't patient growth and optimistic adoption expectations for Bimzelx in a large HS opportunity. UCB is outperforming, with the right strategy to focus on maximizing Bimzelx value. Our €300 PT is ~20-21x 2027E EPS and reflects Bimzelx's €6B+ opportunity in HS and PsA/PsO, with upside.&quot;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27KOL+Survey+Indicates+Continued+HS+Market+Growth%27/25738364.html</guid>
   <pubDate>Mon, 15 Dec 2025 08:42:41 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>TD Cowen on UCB SA (UCB:BB) (UCBJY): 'KOL Survey Indicates Continued HS Market Growth'</title>
   <link>http://www.streetinsider.com/Intl+Ratings/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27KOL+Survey+Indicates+Continued+HS+Market+Growth%27/25738364.html</link>
   <description>&lt;p&gt;TD Cowen analyst Stacy Ku reiterated a Buy rating and EUR300.00 price target on UCB SA (UCB:BB) (OTC: UCBJY).&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;KOL Survey Indicates Continued HS Market Growth And Meaningful Bimzelx Adoption; Investor inbounds are still focused on the HS market dynamics for Bimzelx. All the KOL survey responses point to con't patient growth and optimistic adoption expectations for Bimzelx in a large HS opportunity. UCB is outperforming, with the right strategy to focus on maximizing Bimzelx value. Our €300 PT is ~20-21x 2027E EPS and reflects Bimzelx's €6B+ opportunity in HS and PsA/PsO, with upside.&quot;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27KOL+Survey+Indicates+Continued+HS+Market+Growth%27/25738364.html</guid>
   <pubDate>Mon, 15 Dec 2025 08:42:41 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>TD Cowen on UCB SA (UCB:BB) (UCBJY): 'KOL Survey Indicates Continued HS Market Growth'</title>
   <link>http://www.streetinsider.com/Analyst+Comments/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27KOL+Survey+Indicates+Continued+HS+Market+Growth%27/25738364.html</link>
   <description>&lt;p&gt;TD Cowen analyst Stacy Ku reiterated a Buy rating and EUR300.00 price target on UCB SA (UCB:BB) (OTC: UCBJY).&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;KOL Survey Indicates Continued HS Market Growth And Meaningful Bimzelx Adoption; Investor inbounds are still focused on the HS market dynamics for Bimzelx. All the KOL survey responses point to con't patient growth and optimistic adoption expectations for Bimzelx in a large HS opportunity. UCB is outperforming, with the right strategy to focus on maximizing Bimzelx value. Our €300 PT is ~20-21x 2027E EPS and reflects Bimzelx's €6B+ opportunity in HS and PsA/PsO, with upside.&quot;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27KOL+Survey+Indicates+Continued+HS+Market+Growth%27/25738364.html</guid>
   <pubDate>Mon, 15 Dec 2025 08:42:41 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>TD Cowen on UCB SA (UCB:BB) (UCBJY): 'KOL Survey Indicates Continued HS Market Growth'</title>
   <link>http://www.streetinsider.com/Analyst+Comments/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27KOL+Survey+Indicates+Continued+HS+Market+Growth%27/25738364.html</link>
   <description>&lt;p&gt;TD Cowen analyst Stacy Ku reiterated a Buy rating and EUR300.00 price target on UCB SA (UCB:BB) (OTC: UCBJY).&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;KOL Survey Indicates Continued HS Market Growth And Meaningful Bimzelx Adoption; Investor inbounds are still focused on the HS market dynamics for Bimzelx. All the KOL survey responses point to con't patient growth and optimistic adoption expectations for Bimzelx in a large HS opportunity. UCB is outperforming, with the right strategy to focus on maximizing Bimzelx value. Our €300 PT is ~20-21x 2027E EPS and reflects Bimzelx's €6B+ opportunity in HS and PsA/PsO, with upside.&quot;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/TD+Cowen+on+UCB+SA+%28UCB%3ABB%29+%28UCBJY%29%3A+%27KOL+Survey+Indicates+Continued+HS+Market+Growth%27/25738364.html</guid>
   <pubDate>Mon, 15 Dec 2025 08:42:41 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UBS Reiterates Buy Rating on UCB (UCB:BB) (UCBJY)</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UBS+Reiterates+Buy+Rating+on+UCB+%28UCB%3ABB%29+%28UCBJY%29/25736879.html</link>
   <description>&lt;p&gt;UBS analyst Xian Deng reiterated a Buy rating and EUR300.00 price target on UCB (UCB:BB) (OTC: UCBJY).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UBS+Reiterates+Buy+Rating+on+UCB+%28UCB%3ABB%29+%28UCBJY%29/25736879.html</guid>
   <pubDate>Mon, 15 Dec 2025 04:38:33 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UBS Reiterates Buy Rating on UCB (UCB:BB) (UCBJY)</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UBS+Reiterates+Buy+Rating+on+UCB+%28UCB%3ABB%29+%28UCBJY%29/25736879.html</link>
   <description>&lt;p&gt;UBS analyst Xian Deng reiterated a Buy rating and EUR300.00 price target on UCB (UCB:BB) (OTC: UCBJY).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UBS+Reiterates+Buy+Rating+on+UCB+%28UCB%3ABB%29+%28UCBJY%29/25736879.html</guid>
   <pubDate>Mon, 15 Dec 2025 04:38:33 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR295 at Deutsche Bank</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR295+at+Deutsche+Bank/25709538.html</link>
   <description>Deutsche Bank analyst Emmanuel Papadakis raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR295.00  (from EUR285.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR295+at+Deutsche+Bank/25709538.html</guid>
   <pubDate>Mon, 08 Dec 2025 07:50:20 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR295 at Deutsche Bank</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR295+at+Deutsche+Bank/25709538.html</link>
   <description>Deutsche Bank analyst Emmanuel Papadakis raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR295.00  (from EUR285.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR295+at+Deutsche+Bank/25709538.html</guid>
   <pubDate>Mon, 08 Dec 2025 07:50:20 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
  <item>
   <title>UCB (UCB:BB) (UCBJY) PT Raised to EUR295 at Deutsche Bank</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR295+at+Deutsche+Bank/25709538.html</link>
   <description>Deutsche Bank analyst Emmanuel Papadakis raised the price target on UCB (UCB:BB) (OTC: UCBJY) to EUR295.00  (from EUR285.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/UCB+%28UCB%3ABB%29+%28UCBJY%29+PT+Raised+to+EUR295+at+Deutsche+Bank/25709538.html</guid>
   <pubDate>Mon, 08 Dec 2025 07:50:20 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UCBJY</category>
   	  </item>
 </channel>
</rss>
